Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B–5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark
暂无分享,去创建一个
C. Cooper | Y. Ben-Shlomo | N. Arden | F. Caskey | A. Hermann | A. Judge | M. Nybo | D. Prieto-Alhambra | D. Robinson | M. S. Ali | K. Rubin | M. Javaid | M. Ernst